2013 American Transplant Congress
Effect of CTLA4-Ig on the Fate of Alloreactive Th17 Cells In Vivo, The
Transplantation Research Center, Harvard Medical School, Brigham and Women's Hospital, Boston
The role of Th17:Treg balance in allograft rejection is incompletely understood and remains an active area of investigation. Prior studies have suggested that CD28 costimulation…2013 American Transplant Congress
What Is the Definition of Geographic Equity in Kidney Transplantation?
Northwestern University, Chicago
Purpose: Since the 1990s, a patient’s likelihood of receiving a kidney transplant has highly depended on where a patient resides around the United States. In…2013 American Transplant Congress
Role for DEPTOR in Cell-Intrinsic Mechanisms of Anti-Inflammation in Vascular Endothelial Cells
Recent studies have highlighted a new paradigm whereby the maintenance of normal tissue homeostasis and the prevention of chronic inflammation are dependent on the active…2013 American Transplant Congress
Modification of the Cavaplasty (Hug Procedure) Technique in Liver Transplantation
Westchester Medical Center, Valhalla, NY; First Hospital of Qunming, Qunming, YunNan, China
Introduction: The Cavaplasty OLT, now called Hug Procedure, offers advantages for hepatectomy and implantation and eliminates outflow obstruction. However, caval clamping is required during the…2013 American Transplant Congress
Successful Transplantation of Kidney Allografts in Sensitized Rats Made Possible by Autologous Hematopoietic Stem Cell Transplantation (HSCT) and Fludarabine
We tested whether resetting the immune system with autologous HSC after preconditioning with Fludarabine improves kidney allograft survival in sensitized hosts.Methods: MHC mismatched DA (RT1Aa)…2013 American Transplant Congress
Barriers for Seniors To Get Listed for Kidney Transplantation
Introduction: Kidney transplant (KT) provides patients with improved survival rate and higher quality of life measures, and impose a significantly lower cost on Medicare when…2013 American Transplant Congress
Long-Term Calcineurin Inhibitor (CNI) and Corticosteroid (CS) Avoidance Using Belatacept: The CTOT-10 Experience
Emory Transplant Center; Univ of Alabama-Birmingham; UC-San Francisco; NIAID/NIH; Rho
Belatacept is approved a component of a CNI-free immunosuppressive regimen in EBV + adults undergoing renal transplantation. The intent of this NIH-sponsored CTOT study was…2013 American Transplant Congress
Good Second Kidney Transplant Outcomes in Pediatric Patients with Early First Kidney Graft Loss
Intro:Pediatric kidney transplant (KTx) recipients with early first kidney graft loss(within 30 days) may have graft failure from technical complications or patient disease(hypercoagulability, acute rejection,…2013 American Transplant Congress
Vein/Access Preservation in Kidney Transplant Recipients: Role of Small Bore Internal Jugular Vein (IJV) Catheters
Background: The small bore internal jugular (SBIJ) catheter is to be used for central access in all patients with chronic kidney disease (CKD) Stage 3…2013 American Transplant Congress
Decreased Rejection and Equivalent Survival with Selective Alemtuzumab Induction for Renal Transplantation
University of Maryland School of Medicine, Baltimore, MD
Selective immunosuppressive therapies based on donor and recipient factors should minimize rejection and optimize patient and graft outcomes. We developed in 2006 a selective algorithm…
- « Previous Page
- 1
- …
- 90
- 91
- 92
- 93
- 94
- …
- 178
- Next Page »